Helen M. Burt - Publications

Affiliations: 
University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Pharmacy, Biomedical Engineering, Medicine and Surgery

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jackson J, Leung D, Burt H. The use of ultrasound to increase the uptake and cytotoxicity of dual taxane and P-glycoprotein inhibitor loaded, solid core nanoparticles in drug resistant cells. Ultrasonics. 101: 106033. PMID 31561207 DOI: 10.1016/J.Ultras.2019.106033  0.364
2018 Jackson J, Chen A, Zhang H, Burt H, Chiao M. Design and Near-Infrared Actuation of a Gold Nanorod⁻Polymer Microelectromechanical Device for On-Demand Drug Delivery. Micromachines. 9. PMID 30393302 DOI: 10.3390/Mi9010028  0.345
2018 Pandey R, Jackson JK, Liggins R, Mugabe C, Burt HM. Enhanced taxane uptake into bladder tissues following co-administration with either Mitomycin C, Doxorubicin or Gemcitabine: association to exfoliation processes. Bju International. PMID 29862643 DOI: 10.1111/Bju.14423  0.325
2016 Pandey R, Jackson JK, Mugabe C, Liggins R, Burt HM. Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder. Pharmaceutical Research. PMID 27091034 DOI: 10.1007/S11095-016-1920-6  0.304
2014 Wan CP, Letchford K, Leung D, Jackson JK, Burt HM. Mixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicity. Journal of Pharmaceutical Sciences. 103: 3966-76. PMID 25318668 DOI: 10.1002/Jps.24208  0.373
2014 Khamenehfar A, Wan CP, Li PC, Letchford K, Burt HM. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation. Analytical and Bioanalytical Chemistry. 406: 7071-83. PMID 25315452 DOI: 10.1007/S00216-014-8151-7  0.394
2013 Gilchrist SE, Lange D, Letchford K, Bach H, Fazli L, Burt HM. Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. Journal of Controlled Release : Official Journal of the Controlled Release Society. 170: 64-73. PMID 23639451 DOI: 10.1016/J.Jconrel.2013.04.012  0.307
2013 Wan CP, Letchford K, Jackson JK, Burt HM. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance. International Journal of Nanomedicine. 8: 379-91. PMID 23378760 DOI: 10.2147/Ijn.S38737  0.406
2012 Chakraborti M, Jackson JK, Plackett D, Gilchrist SE, Burt HM. The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics. Journal of Materials Science. Materials in Medicine. 23: 1705-13. PMID 22528072 DOI: 10.1007/S10856-012-4638-Y  0.372
2012 Gilchrist SE, Rickard DL, Letchford K, Needham D, Burt HM. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. Molecular Pharmaceutics. 9: 1489-501. PMID 22482935 DOI: 10.1021/Mp300099F  0.357
2012 Wan CP, Jackson JK, Pirmoradi FN, Chiao M, Burt HM. Increased accumulation and retention of micellar paclitaxel in drug-sensitive and P-glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound in Medicine & Biology. 38: 736-44. PMID 22425383 DOI: 10.1016/J.Ultrasmedbio.2012.01.023  0.351
2012 Letchford K, Burt HM. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Molecular Pharmaceutics. 9: 248-60. PMID 22204437 DOI: 10.1021/Mp2002939  0.403
2012 Mugabe C, Raven PA, Fazli L, Baker JH, Jackson JK, Liggins RT, So AI, Gleave ME, Minchinton AI, Brooks DE, Burt HM. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium. Biomaterials. 33: 692-703. PMID 22014457 DOI: 10.1016/J.Biomaterials.2011.09.081  0.304
2011 Jackson J, Leung F, Duncan C, Mugabe C, Burt H. The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength. Drug Delivery and Translational Research. 1: 121-31. PMID 25788111 DOI: 10.1007/S13346-011-0015-5  0.349
2011 Chakraborti M, Jackson JK, Plackett D, Brunette DM, Burt HM. Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. International Journal of Pharmaceutics. 416: 305-13. PMID 21708236 DOI: 10.1016/J.Ijpharm.2011.06.016  0.382
2011 Pirmoradi FN, Jackson JK, Burt HM, Chiao M. On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. Lab On a Chip. 11: 2744-52. PMID 21698338 DOI: 10.1039/C1Lc20134D  0.334
2011 Jackson JK, Letchford K, Wasserman BZ, Ye L, Hamad WY, Burt HM. The use of nanocrystalline cellulose for the binding and controlled release of drugs. International Journal of Nanomedicine. 6: 321-30. PMID 21383857 DOI: 10.2147/Ijn.S16749  0.36
2011 Ye L, Letchford K, Heller M, Liggins R, Guan D, Kizhakkedathu JN, Brooks DE, Jackson JK, Burt HM. Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin. Biomacromolecules. 12: 145-55. PMID 21128674 DOI: 10.1021/Bm101080P  0.362
2011 Mugabe C, Liggins RT, Guan D, Manisali I, Chafeeva I, Brooks DE, Heller M, Jackson JK, Burt HM. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols. International Journal of Pharmaceutics. 404: 238-49. PMID 21093563 DOI: 10.1016/J.Ijpharm.2010.11.010  0.392
2010 Tsallas A, Jackson J, Burt H. The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations. Cancer Chemotherapy and Pharmacology. 68: 431-44. PMID 21069339 DOI: 10.1007/S00280-010-1499-2  0.367
2010 Owen GR, Jackson JK, Chehroudi B, Brunette DM, Burt HM. An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics. Journal of Biomedical Materials Research. Part A. 95: 857-69. PMID 20824651 DOI: 10.1002/Jbm.A.32865  0.401
2009 Long KA, Jackson JK, Yang C, Chehroudi B, Brunette DM, Burt HM. Controlled release of alendronate from polymeric films. Journal of Biomaterials Science. Polymer Edition. 20: 653-72. PMID 19323882 DOI: 10.1163/156856209X426457  0.401
2009 Haxton KJ, Burt HM. Polymeric drug delivery of platinum-based anticancer agents. Journal of Pharmaceutical Sciences. 98: 2299-316. PMID 19009590 DOI: 10.1002/Jps.21611  0.35
2009 Letchford K, Liggins R, Wasan KM, Burt H. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 71: 196-206. PMID 18762253 DOI: 10.1016/J.Ejpb.2008.08.003  0.395
2009 Elamanchili P, McEachern C, Burt H. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function. Journal of Pharmaceutical Sciences. 98: 945-958. PMID 18623213 DOI: 10.1002/Jps.21479  0.348
2008 Haxton KJ, Burt HM. Hyperbranched polymers for controlled release of cisplatin. Dalton Transactions (Cambridge, England : 2003). 5872-5. PMID 19082039 DOI: 10.1039/B809949A  0.363
2008 Zastre JA, Jackson JK, Wong W, Burt HM. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity. Molecular Pharmaceutics. 5: 643-53. PMID 18380467 DOI: 10.1021/Mp7001347  0.7
2008 Kainthan RK, Mugabe C, Burt HM, Brooks DE. Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: ligand binding properties. Biomacromolecules. 9: 886-95. PMID 18247528 DOI: 10.1021/Bm701208P  0.363
2008 Springate CM, Jackson JK, Gleave ME, Burt HM. Clusterin antisense complexed with chitosan for controlled intratumoral delivery. International Journal of Pharmaceutics. 350: 53-64. PMID 17890029 DOI: 10.1016/J.Ijpharm.2007.08.018  0.354
2008 Letchford K, Liggins R, Burt H. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. Journal of Pharmaceutical Sciences. 97: 1179-90. PMID 17683080 DOI: 10.1002/Jps.21037  0.401
2007 Jackson JK, Hung T, Letchford K, Burt HM. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. International Journal of Pharmaceutics. 342: 6-17. PMID 17555895 DOI: 10.1016/J.Ijpharm.2007.04.022  0.423
2007 Zastre J, Jackson JK, Wong W, Burt HM. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity. Journal of Pharmaceutical Sciences. 96: 864-75. PMID 17094135 DOI: 10.1002/Jps.20785  0.687
2006 Yang C, Burt HM. Drug-eluting stents: factors governing local pharmacokinetics. Advanced Drug Delivery Reviews. 58: 402-11. PMID 16616969 DOI: 10.1016/J.Addr.2006.01.017  0.303
2005 Springate CM, Jackson JK, Gleave ME, Burt HM. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemotherapy and Pharmacology. 56: 239-47. PMID 15864591 DOI: 10.1007/S00280-004-0997-5  0.307
2004 Jackson JK, Smith J, Letchford K, Babiuk KA, Machan L, Signore P, Hunter WL, Wang K, Burt HM. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. International Journal of Pharmaceutics. 283: 97-109. PMID 15363506 DOI: 10.1016/J.Ijpharm.2004.06.025  0.371
2004 Zastre J, Jackson J, Burt H. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers. Pharmaceutical Research. 21: 1489-97. PMID 15359586 DOI: 10.1023/B:Pham.0000036925.45002.A2  0.708
2004 Liggins RT, Burt HM. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. International Journal of Pharmaceutics. 282: 61-71. PMID 15336382 DOI: 10.1016/J.Ijpharm.2004.05.026  0.301
2004 Liggins RT, Cruz T, Min W, Liang L, Hunter WL, Burt HM. Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 53: 363-72. PMID 15316667 DOI: 10.1007/S00011-004-1273-1  0.328
2004 Cashman J, Burt HM, Springate C, Gleave J, Jackson JK. Camptothecin-loaded films for the prevention of postsurgical adhesions. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 53: 355-62. PMID 15316666 DOI: 10.1007/S00011-004-1272-2  0.314
2004 Liggins RT, Burt HM. Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics. International Journal of Pharmaceutics. 281: 103-6. PMID 15288347 DOI: 10.1016/J.Ijpharm.2004.05.027  0.375
2004 Letchford K, Zastre J, Liggins R, Burt H. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers. Colloids and Surfaces. B, Biointerfaces. 35: 81-91. PMID 15261040 DOI: 10.1016/J.Colsurfb.2004.02.012  0.716
2004 Shi R, Burt HM. Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel. International Journal of Pharmaceutics. 271: 167-79. PMID 15129983 DOI: 10.1016/J.Ijpharm.2003.11.005  0.73
2004 Liang LS, Jackson J, Min W, Risovic V, Wasan KM, Burt HM. Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. Journal of Pharmaceutical Sciences. 93: 943-56. PMID 14999731 DOI: 10.1002/Jps.20031  0.363
2004 Jackson JK, Zhang X, Llewellen S, Hunter WL, Burt HM. The characterization of novel polymeric paste formulations for intratumoral delivery. International Journal of Pharmaceutics. 270: 185-98. PMID 14726134 DOI: 10.1016/J.Ijpharm.2003.10.010  0.421
2003 Shi R, Burt HM. Synthesis and characterization of amphiphilic hydroxypropylcellulose-graft-poly(?-caprolactone) Journal of Applied Polymer Science. 89: 718-727. DOI: 10.1002/App.12194  0.725
2002 Zastre J, Jackson J, Bajwa M, Liggins R, Iqbal F, Burt H. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 54: 299-309. PMID 12445560 DOI: 10.1016/S0939-6411(02)00119-4  0.705
2002 Jackson JK, Liang LS, Hunter WL, Reynolds M, Sandberg JA, Springate C, Burt HM. The encapsulation of ribozymes in biodegradable polymeric matrices. International Journal of Pharmaceutics. 243: 43-55. PMID 12176294 DOI: 10.1016/S0378-5173(02)00228-4  0.355
2002 Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharmaceutical Research. 19: 411-7. PMID 12033372 DOI: 10.1023/A:1015175108183  0.336
2002 Liggins RT, Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Advanced Drug Delivery Reviews. 54: 191-202. PMID 11897145 DOI: 10.1016/S0169-409X(02)00016-9  0.406
2001 Liggins RT, Burt HM. Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. International Journal of Pharmaceutics. 222: 19-33. PMID 11404029 DOI: 10.1016/S0378-5173(01)00690-1  0.39
2000 Liggins RT, D'Amours S, Demetrick JS, Machan LS, Burt HM. Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. Biomaterials. 21: 1959-69. PMID 10941917 DOI: 10.1016/S0142-9612(00)00080-6  0.338
2000 Jackson JK, Springate CM, Hunter WL, Burt HM. Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of pluronic F127. Biomaterials. 21: 1483-91. PMID 10872777 DOI: 10.1016/S0142-9612(00)00034-X  0.334
1999 Burt HM, Zhang X, Toleikis P, Embree L, Hunter WL. Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel Colloids and Surfaces B: Biointerfaces. 16: 161-171. DOI: 10.1016/S0927-7765(99)00067-3  0.393
1997 Hunter WL, Burt HM, Machan L. Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents. Advanced Drug Delivery Reviews. 26: 199-207. PMID 10837543 DOI: 10.1016/S0169-409X(97)00035-5  0.309
1997 Zhang X, Burt HM, Von Hoff D, Dexter D, Mangold G, Degen D, Oktaba AM, Hunter WL. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel Cancer Chemotherapy and Pharmacology. 40: 81-86. PMID 9137535 DOI: 10.1007/S002800050630  0.36
1997 Jackson JK, Min W, Cruz TF, Cindric S, Arsenault L, Von Hoff DD, Degan D, Hunter WL, Burt HM. A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice. British Journal of Cancer. 75: 1014-20. PMID 9083337 DOI: 10.1038/Bjc.1997.174  0.395
1997 Dordunoo S, Oktaba A, Hunter W, Min W, Cruz T, Burt H. Release of taxol from poly(ϵ-caprolactone) pastes: effect of water-soluble additives Journal of Controlled Release. 44: 87-94. DOI: 10.1016/S0168-3659(96)01510-6  0.357
1996 Winternitz CI, Jackson JK, Oktaba AM, Burt HM. Development of a polymeric surgical paste formulation for taxol. Pharmaceutical Research. 13: 368-75. PMID 8692727 DOI: 10.1023/A:1016032207246  0.316
1996 Zhang X, Jackson JK, Wong W, Min W, Cruz T, Hunter WL, Burt HM. Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study International Journal of Pharmaceutics. 137: 199-208. DOI: 10.1016/0378-5173(96)04521-8  0.388
1996 Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol International Journal of Pharmaceutics. 132: 195-206. DOI: 10.1016/0378-5173(95)04386-1  0.39
1995 Dordunoo SK, Jackson JK, Arsenault LA, Oktaba AM, Hunter WL, Burt HM. Taxol encapsulation in poly(epsilon-caprolactone) microspheres. Cancer Chemotherapy and Pharmacology. 36: 279-82. PMID 7543028 DOI: 10.1007/Bf00689043  0.389
1995 Burt HM, Jackson JK, Bains SK, Liggins RT, Oktaba AM, Arsenault AL, Hunter WL. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). Cancer Letters. 88: 73-9. PMID 7531612 DOI: 10.1016/0304-3835(94)03614-O  0.393
Show low-probability matches.